Compliance

  • April 14, 2026

    American Flag Seller Settles FTC's False 'Made In USA' Claims

    The Federal Trade Commission announced Tuesday that it has reached settlements with three businesses, including a company that sells American flags and other patriotic products, over claims that they falsely advertised and labeled products as "Made in the USA."

  • April 14, 2026

    2 Bills To Shield Kids From Online Harms Clear Senate Panel

    A pair of bipartisan legislative proposals to boost online safeguards for children sailed through a key U.S. Senate committee Tuesday, including a measure that would require social media platforms to display clear mental health warning labels each time a user accesses the service.

  • April 14, 2026

    Armistice Capital Used COVID To Juice Vaxart Stock, Jury Told

    Hedge fund Armistice Capital and two of its executives exploited the COVID-19 pandemic to issue press releases that falsely inflated their controlling share in pharmaceutical company Vaxart, then dumped the shares for $250 million before the bottom fell out, investors told a California federal jury at the start of trial Tuesday.

  • April 14, 2026

    4th Circ. Revives Pharma Bid To Block Maryland's 340B Law

    A split Fourth Circuit panel on Tuesday tossed a Maryland district court's order denying a preliminary injunction to pharmaceutical manufacturers that have challenged a state law addressing drug delivery in the federal 340B discount program, pointing to its recent ruling that West Virginia's similar statute is likely preempted.

  • April 14, 2026

    Westlake Inks $67M Antitrust Deal With PVC Pipe Buyers

    Purchasers of polyvinyl chloride pipe urged an Illinois federal judge Tuesday to sign off on a proposed $67 million deal with Westlake Corp. that would put to rest allegations it and other PVC pipe producers conspired to fix prices, according to a motion filed in Illinois federal court.

  • April 14, 2026

    AI Security Co. Investors Seek 1st OK For $15M Settlement

    Investors in Evolv Technologies Holdings Inc. seek an initial nod for a $15 million deal to settle proposed class action claims that the company overstated the effectiveness of its flagship artificial intelligence-powered weapon detection service and improperly recognized millions in revenue from unpaid trial deals with customers.

  • April 14, 2026

    States Denied Time For Talks To Settle Drug Price-Fixing Suit

    A Connecticut federal judge Tuesday denied a request by dozens of U.S. states to freeze their antitrust case against generic-drug manufacturers, a pause the states argued would allow the parties to focus on settlement talks rather than pending discovery and motion deadlines.

  • April 14, 2026

    Justices Told That Eli Lilly's FCA Qui Tam Challenge Too Late

    A whistleblower who secured a $183 million trial win against Eli Lilly urged the U.S. Supreme Court on Tuesday to reject its constitutional challenge over his ability to sue for the federal government, arguing the drugmaker's arguments came too late.

  • April 14, 2026

    Turkey Cos. Denied Response To DOJ Price-Fix Intervention

    An Illinois federal judge refused Friday to let Agri Stats, Tyson Foods and other turkey producers respond to the Justice Department statement of interest weighing in on private price-fixing litigation against them, finding "no need" when the court is already obligated to consider the legal precedent the agency raised.

  • April 14, 2026

    Virginia Latest State To Ban Precise Location Data Sales

    Virginia has become the third state to ban the sale of consumers' precise geolocation data, following the governor's signature on Monday of legislation that received overwhelming backing from lawmakers and consumer advocates, and backlash from the advertising industry. 

  • April 14, 2026

    Ex-CFTC Chair Departs Willkie, Law Practice For Fintech Work

    The former leader of the nation's derivatives regulator dubbed "Crypto Dad" says he's leaving his law practice at Willkie Farr & Gallagher LLP to focus on advising fintechs and crypto firms, researching public policy issues and working with nonprofit programs.

  • April 14, 2026

    SEC Greenlights Rule Lifting Day Trader Equity Requirement

    The U.S. Securities and Exchange Commission on Tuesday approved eliminating a requirement that active day traders maintain a minimum amount of money in their accounts, with the Financial Industry Regulatory Authority saying the changes to its rules will give retail investors a greater chance to participate in the markets.

  • April 14, 2026

    Pomerantz To Lead Chinese Logistics Co. Investor Suit

    Attorneys from Pomerantz LLP will lead a proposed class action alleging the share prices of China-based Jayud Global Logistics Ltd. were artificially inflated through fake social media posts hyping the company before suddenly collapsing by 95% in one day.

  • April 14, 2026

    Apple Users Slam 'Distorted' Antitrust Depo Sanctions Bid

    Phone users who accuse Google of suppressing rival search engines with anticompetitive deals slammed Apple's bid for sanctions over their counsel's allegedly "unrelenting and increasingly egregious" subpoena efforts, telling a California federal judge that the tech company's motion is based on a "distorted account of the discovery record."

  • April 14, 2026

    Trump's Fed Chair Pick Will Get Senate Hearing Next Week

    The Senate Banking Committee will meet next week to vet Kevin Warsh as President Donald Trump's nominee as the next leader of the Federal Reserve, moving forward with his confirmation process despite bipartisan protests over a still-pending probe of current Fed Chair Jerome Powell.

  • April 14, 2026

    Trade Group Latest To Sue Wash. Over 340B Drug Pricing Law

    Pharmaceutical Research and Manufacturers of America claims a new Washington state law attempts to illegally reshape the federal 340B Drug Pricing Program and singles out participating drugmakers with burdensome regulations, according to a fresh federal lawsuit that follows similar constitutional challenges mounted by Novartis and AbbVie.

  • April 14, 2026

    Trump Signs Revised HEAR Act For Nazi-Looted Art

    President Donald Trump has signed into law the Holocaust Expropriated Art Recovery Act of 2025, which amends the original 2016 act to establish procedures for civil claims seeking to recover artwork and other property lost between 1933 and 1945 due to Nazi persecution.

  • April 14, 2026

    11th Circ. Grounds Jet Co.'s Defamation Suit Against Chase

    The Eleventh Circuit on Tuesday backed JPMorgan Chase & Co.'s early win in a lawsuit brought by a jet chartering company alleging it was defamed as it was placed on an internal blacklist, ruling that the bank hadn't made any false statements in explaining to customers why it blocked the company's transactions.

  • April 14, 2026

    Red State AGs Fight Bid To Trim Suit Against BlackRock

    Republican attorneys general are opposing a bid by BlackRock and State Street to trim a suit accusing the asset managers of driving up coal prices, arguing that the firms' assertion that the suit cannot get past the U.S. Supreme Court's decision on federal antitrust damages claims is incorrect.

  • April 14, 2026

    IBM's FCA Deal Creates Unease Over DEI Enforcement Scope

    IBM's agreement to pay the Trump administration $17 million to resolve allegations it violated the False Claims Act with policies aimed at increasing the diversity of its workforce continues to raise more questions than answers about what the administration views as illegal diversity, equity and inclusion programs.

  • April 14, 2026

    Proxy Co. Sues Ind. AG Over 'Unconstitutional' Disclosure Law

    Institutional Shareholder Services Inc. has sued Indiana's attorney general over a law the proxy adviser said violates the First and Fourteenth amendments and imposes onerous disclosure requirements for issuing recommendations that go against the preferred outcome of corporate managers.

  • April 14, 2026

    Tabloid Tells NY Court Epstein Files Release Isn't Complete

    An internet tabloid renewed its efforts to obtain investigative files on the late sex offender Jeffrey Epstein and urged a New York federal court to reconsider a decision blocking a public records request to the FBI, arguing that a documents release pursuant to an act of Congress isn't complete. 

  • April 14, 2026

    EPA Sued Over Missed Deadline For Tougher Soot Limits

    A group of 17 organizations including the Sierra Club and the American Lung Association sued the head of the U.S. Environmental Protection Agency in California federal court Monday, alleging that the agency failed to meet a deadline to strengthen national air standards for soot.

  • April 14, 2026

    Meta, Others Can't Look At Internal Data To Probe Jury Pool

    A California federal judge on Tuesday granted an uncontested bid by school district plaintiffs to bar Meta and other social media companies from using nonpublic information — including their internal data — to investigate potential jurors for an upcoming bellwether trial in multidistrict litigation over the alleged harms of social media addiction.

  • April 14, 2026

    Michigan Judge OKs $13 Million Deal In Debt Collection Suit

    A Michigan federal judge has given final approval for a $13.1 million settlement to a class of some 5,300 debtors who complained that a creditor law firm charged unlawfully high post-judgment interest rates during debt collection.

Expert Analysis

  • What Cos. Must Know About Pa.'s Proposed Data Center Regs

    Author Photo

    Under Pennsylvania Gov. Josh Shapiro's new proposal to balance hyperscale data center infrastructure with grid stability, water resources and community transparency, businesses in the state face a strategic choice: wait for binding requirements to emerge, or proactively align projects with the standards now, say Wade Stephens and Sasha Burton at Langsam Stevens.

  • Lessons From Justices' Split On Major Questions Doctrine

    Author Photo

    The justices' varied opinions in Learning Resources v. Trump, which held the International Emergency Economy Powers Act did not confer the power to impose tariffs, offer a meaningful window into the U.S. Supreme Court's perspective on the major questions doctrine that will likely shape lower courts' approach to executive action challenges, say attorneys at Venable.

  • Drug Wholesaler's DPA Shows Imperfect Efforts Still Count

    Author Photo

    Atlantic Biologicals’ recent deferred prosecution agreement with federal prosecutors for allegedly distributing controlled substances to pill mill pharmacies demonstrates that even subpar cooperation, when combined with genuine remediation and strategic advocacy, can yield outcomes that protect a company's long-term interests, says Jonathan Porter at Husch Blackwell.

  • Share Repurchases Leave Cos. Susceptible To Litigation

    Author Photo

    Because share repurchases bring greater ownership, which typically brings greater voting power, they can have serious implications for corporate control, which can raise questions about the unpaid benefits to some shareholders and lead to securities class actions, says Amit Bubna at Bates White.

  • Resilience Planning As Nat'l Security Shifts Tech Import Policy

    Author Photo

    In response to a sustained reorientation of U.S. trade policy around national security considerations, businesses reliant on processed critical minerals must closely monitor diplomatic negotiations and the potential expansion of trade measures, incorporating contingency planning into procurement and long-term investment strategies, says attorney Sohan Dasgupta.

  • Proposed DOL Rule Could Simplify Contractor Classification

    Author Photo

    If the U.S. Department of Labor's recently proposed rule governing employee versus independent contractor classification is finalized, it would permit energy sector employers to evaluate the nature of the working relationship with a more straightforward and predictable analysis than the 2024 rule's unweighted test, say attorneys at Bracewell.

  • Key Takeaways As HRSA Aims To Revive 340B Rebate Pilot

    Author Photo

    The U.S. Department of Health and Human Services' recent request for feedback on the 340B Rebate Model Pilot Program demonstrates that it intends to correct the model's procedural defects, which is positive news for participating manufacturers, but a setback for covered entities, say attorneys at Manatt.

  • How The New Tariff Landscape May Unfold

    Author Photo

    To replace tariffs formerly imposed under the International Emergency Economic Powers Act, the administration will rely on a patchwork of statutes, potentially leading to procedural challenges and a complex tariff landscape with varying levels, durations and applicability, says Joseph Grossman-Trawick at King & Spalding.

  • 4th Circ. Navy Federal Decision Illustrates Nuances Of Rule 23

    Author Photo

    The Fourth Circuit's recent decision in Oliver v. Navy Federal Credit Union helpfully clarified how class action defendants can use Rule 23(c)(1)(A) to eliminate exposure early, along with the limitations of such an approach, say attorneys at Duane Morris.

  • Assessing Ruling On SEC Industry Bars In Post-Jarkesy World

    Author Photo

    According to a D.C. federal court in Sztrom v. U.S. Securities and Exchange Commission, the U.S. Supreme Court's 2024 decision in SEC v. Jarkesy did not eliminate the commission's ability to pursue industry bars through administrative follow-on proceedings, a major blow for future Article 3 challenges — so long as it stands, say attorneys at Venable.

  • What Orgs. Should Note In IRS Group Tax Exemption Overhaul

    Author Photo

    In a significant update, the IRS Revenue Procedure 2026-8 shows that the group exemption program is moving into a new regulatory era involving more uniformity, oversight and compliance obligations, and early action is key to preserve group exemption status and avoid disruption for subordinate organizations, says Ravi Sundara at Spencer Fane.

  • What GCs Should Keep In Mind When Developing AI Addenda

    Author Photo

    When general counsel develop their own customer-side artificial intelligence addenda to be used as the baseline for negotiations with AI vendors, they should take care to rightsize the addenda relative to their organization's size, complexity and bargaining power, say attorneys at Polsinelli.

  • How DOJ Is Rethinking Corporate Crime Prosecution Tactics

    Author Photo

    Recent statements from the Justice Department seem to indicate an incremental shift away from relying on collective employee knowledge when prosecuting corporate crime, and from exploring the bounds of case law that has not been a model of clarity, say attorneys at Covington.

  • 5 Key Issues Affecting Deal Structurings In Ship Finance

    Author Photo

    Several trends are shaping the ship finance landscape, including the impact of Basel IV in Europe and the Nordic bond market, making it essential for both lenders and shipowners to utilize creative deal structuring and maintain an awareness of competitive dynamics across traditional bank and private lending, say attorneys at Holland & Knight.

  • Character.AI Case Highlights Agentic AI Liability Questions

    Author Photo

    The recently settled litigation against Character Technologies Inc. provides an early case study for exploring salient legal issues related to agentic artificial intelligence, such as tort liability, strict liability, statutory liability and contractual liability, says Samuel Mitchells at Smith Gambrell.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Compliance archive.